India  

FDA to vote on J&J COVID-19 booster shoots; also looking into mixing and matching vaccine doses

Video Credit: ABC Action News - Duration: 02:13s - Published
FDA to vote on J&J COVID-19 booster shoots; also looking into mixing and matching vaccine doses

FDA to vote on J&J COVID-19 booster shoots; also looking into mixing and matching vaccine doses

On Friday, the Food and Drug Administration Advisory Committee will review safety and efficacy data to see if they should expand Johnson & Johnson's emergency use authorization to include a booster shot for its COVID-19 vaccine.

Https://www.abcactionnews.com/news/coronavirus/fda-to-vote-on-j-j-covid-19-booster-shoots-also-looking-into-mixing-and-matching-vaccine-doses


You Might Like


💡 newsR Knowledge: Other News Mentions

Food and Drug Administration Food and Drug Administration Agency of the US Department of Health and Human Services

FDA Advisers Narrowly Endorse Merck’s COVID Antiviral Pill [Video]

FDA Advisers Narrowly Endorse Merck’s COVID Antiviral Pill

FDA Advisers Narrowly Endorse , Merck’s COVID Antiviral Pill. On Nov. 30, the FDA's Antimicrobial Drugs Advisory Committee voted to endorse Merck's molnupiravir pill for use in treating COVID-19 in high-risk adults. On Nov. 30, the FDA's Antimicrobial Drugs Advisory Committee voted to endorse Merck's molnupiravir pill for use in treating COVID-19 in high-risk adults. The vote was 13-10. The panel's decision could prompt the agency to grant Merck emergency use authorization, which the U.K. has already done. CBS News reports the Biden administration has already bought about 3.1 million courses of the treatment, which is given to patients over five days. CBS News reports the Biden administration has already bought about 3.1 million courses of the treatment, which is given to patients over five days. This is the first opportunity that an oral outpatient medication for mildly symptomatic to moderate symptomatic persons would be available, Dr. W. David Hardy, a scientist at Charles Drew University School of Medicine and Science and panel member, via CBS News. Those in opposition debated the rare risk that the drug, which relies on triggering mutations of the virus, might unleash a new variant. Even if the probability is very low, one in 10,000 to one in 100,000, that this drug would induce an escape mutant for which the vaccines we have do not cover, that would be catastrophic for the whole world actually, Dr. James Hildreth, one of the panel's advisers, via CBS News. CBS News reports Merck admitted it did not have the data to accurately estimate that risk, but no one who took the pills appeared to be infectious. Additionally, Merck's most recent trial data revealed a 30% efficacy rate as opposed to its initial claim of reducing the risk of hospitalization or death by 50%. Additionally, Merck's most recent trial data revealed a 30% efficacy rate as opposed to its initial claim of reducing the risk of hospitalization or death by 50%

Credit: Wibbitz Top Stories    Duration: 01:30Published
Vaccine Expert: Everyone on FDA panel would vaccinate their own child [Video]

Vaccine Expert: Everyone on FDA panel would vaccinate their own child

Dr. Paul Offit, pediatrician, vaccine pioneer and author of “You Bet Your Life,” explains the risk inherent in every major medical breakthrough

Credit: Bleacher Report AOL    Duration: 10:12Published
FDA authorizes Pfizer's Covid-19 vaccine for children 5 to 11 [Video]

FDA authorizes Pfizer's Covid-19 vaccine for children 5 to 11

CNN’s Nick Watt reports.

Credit: Bleacher Report AOL    Duration: 02:49Published
The American Academy of Pediatrics welcomes FDA's decision to authorize Pfizer's Covid-19 vaccine for children 5 to 11 [Video]

The American Academy of Pediatrics welcomes FDA's decision to authorize Pfizer's Covid-19 vaccine for children 5 to 11

Dr. Lee Savio Beers discusses with CNN’s Jake Tapper.

Credit: Bleacher Report AOL    Duration: 04:18Published

COVID-19 COVID-19 Contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

After protests, Rajya Sabha clears dam bill, Lok Sabha sees 117% productivity

Despite protests and some disruptions, Parliament reflected a semblance of normalcy on Thursday with the Lok Sabha discussing the Covid situation and the Rajya..
IndiaTimes
US Government Approaches Possible Shutdown [Video]

US Government Approaches Possible Shutdown

US Government , Approaches Possible Shutdown. 'The Washington Post' reports the United States government is headed for a potential shutdown. As a crucial fiscal government deadline draws near, Republican officials seized an opportunity to voice their opposition to Biden's proposed vaccine mandates. Congressional in-fighting threatens to put a wrench in bipartisan cooperation. According to ABC News, the current agreement on federal spending will expire on December 3 at midnight. According to ABC News, the current agreement on federal spending will expire on December 3 at midnight. President Biden's proposed vaccine mandate is intended to hold larger private businesses accountable by requiring vaccination and implementing more precise testing. President Biden's proposed vaccine mandate is intended to hold larger private businesses accountable by requiring vaccination and implementing more precise testing. 'The Washington Post' reports that the ongoing COVID-19 pandemic has ended the lives of over 780,000 Americans. 'The Washington Post' reports that the ongoing COVID-19 pandemic has ended the lives of over 780,000 Americans. The ongoing COVID-19 pandemic has ended the lives of over 780,000 Americans. With news of the first known case of the omicron strain in the United States, Republicans continue to rail against public health measures that intend to curb the spread of COVID-19. With news of the first known case of the omicron strain in the United States, Republicans continue to rail against public health measures that intend to curb the spread of COVID-19. I hope they see the light quickly and not cause a needless Republican government shutdown. , Chuck Schumer, Senate Majority Leader, via The Washington Post. I hope they see the light quickly and not cause a needless Republican government shutdown. , Chuck Schumer, Senate Majority Leader, via The Washington Post. Many Republicans seem unwilling to negotiate. Democrats say such obstructions are "totally irresponsible." . Many Republicans seem unwilling to negotiate. Democrats say such obstructions are "totally irresponsible." . It’s just amazing to me. Hundreds of thousands of people have died... , Debbie Stabenow, Senator Michigan, via The Washington Post. It’s just amazing to me. Hundreds of thousands of people have died... , Debbie Stabenow, Senator Michigan, via The Washington Post

Credit: Wibbitz Top Stories    Duration: 01:30Published

Parliament Covid discussion: Opposition says govt favoured BJP states

On the day when India reported two confirmed cases of new Corona variant Omicron, Lok Sabha on Thursday took up debate on the Covid situation in the country with..
IndiaTimes

Covid vaccination: Coverage of 1st dose up by 5.9%, second shot by 11.7%

The coverage of the first and second dose of Covid vaccine has increased by 5.9% and 11.7%, respectively, till end of November following the government’s..
IndiaTimes

Covid-19: A wide range of vaccines act as booster to AstraZeneca, Pfizer shots, says study

Up to six different Covid-19 boosters were found to be safe, and provoked strong immune responses in people who have previously received a two-dose course of the..
IndiaTimes

Johnson & Johnson Johnson & Johnson U.S. multinational medical manufacturer

Johnson & Johnson is splitting into two companies [Video]

Johnson & Johnson is splitting into two companies

Johnson & Johnson is separating the consumer health products part of the business from the prescription drugs and medical devices unit. CNN’s Paul R. La Monica reports.

Credit: Bleacher Report AOL    Duration: 01:29Published
Man with rare condition after J&J vaccine wants people to get vaccinated [Video]

Man with rare condition after J&J vaccine wants people to get vaccinated

Anthony Flint, who claims to have developed Guillain-Barré syndrome after his Johnson & Johnson Covid-19 vaccination, discusses the rare autoimmune disorder and why he is still urging others to get vaccinated.

Credit: Bleacher Report AOL    Duration: 04:00Published

Related videos from verified sources

In-Depth: Vaccine providers hope expanded booster guidelines boost demand [Video]

In-Depth: Vaccine providers hope expanded booster guidelines boost demand

Vaccine providers hope the CDC's new booster guidelines eliminate confusion over who should get the shots.

Credit: ABC 10 News | San Diego     Duration: 03:16Published
COVID Boosters for All Adults Get FDA Approval, Await CDC Review [Video]

COVID Boosters for All Adults Get FDA Approval, Await CDC Review

COVID Boosters , for All Adults Get FDA Approval, , Await CDC Review. On November 19, regulators in the United States approved COVID-19 booster shots for all adults, an expansion of the..

Credit: Wibbitz Top Stories     Duration: 01:30Published
Pediatric COVID-19 cases in Michigan nearing record levels, leaving doctors concerned [Video]

Pediatric COVID-19 cases in Michigan nearing record levels, leaving doctors concerned

The FDA appears to be nearing the authorization of a COVID-19 booster for all adults. It comes amid the growing number of COVID-19 infections in kids.

Credit: WXYZ Detroit     Duration: 02:11Published